Conservative management of upper limb fractures in frailty

Regular Off Off

2021:  BGS Autumn meeting platform presentation abstract

805 Clinical quality – clinical effectiveness

L Shaw; T Maggs; P Braude; D Shipway; S Srivastava; M Kelly 

Introduction

Upper limb fractures are the second most common fracture requiring admission to hospital after hip fracture [Jennison, 2019].  At 1-year 20.5% have died, compared to 29.5% in hip fracture [Wiedl, 2021].     Local Problems:  At North Bristol Trust most patients with upper limb fractures and a Clinical Frailty Score ≥ 5 are managed non-operatively on medical wards. Local service evaluation identified a long length of stay of 23 days.    Case note review revealed:  ∙ Delayed transfers of care (DTOCs) had been managed non-weight bearing in slings for 4-6 weeks.  ∙ Non-weight bearing status resulted in DTOC due to declined access to social care and rehabilitation due to perceived health needs.  ∙ A high rate of hospital-acquired complications and failure to rehabilitate.  ∙ Breakdown in interdisciplinary communication and ownership across the pathway.     

Methods

A multidisciplinary QI project was commenced.  Using local data through business analytics, clinician and patient feedback, a new Trust guideline was developed for older people with frailty and upper limb fractures. Data collected determined average length of stay before and after implementation of the service change.  A standard process control chart was created monitoring the effect of the changes in the pathway. The multidisciplinary team met regularly to make alterations during implementation.    The resulting intervention included:  ∙ Removal of functional restrictions; allow free use of limb as comfort permits.   ∙ Simplified slings and minimised light weight casts.  ∙ Proactive integration of orthopaedic plan into CGA documentation.  ∙ Proactive interdisciplinary communication across pathways.  ∙ Patient information leaflets.     

Results

Pre-intervention average length of stay was 23 days. Post-intervention was 14 days.     

Conclusion

Proactive, structured management of upper limb fractures in people with frailty is associated with significant reduction in acute hospital length of stay.  Next steps include a business case for a frailty trauma specialist therapist embedded into medicine.

Addendum 2023

Additional thanks for ongoing support from Tahid Alam,  Alasdair Bott, Andrew Riddick, Frances Verey, Lynn Hutchings, Nathanael Ahearn

Test Information

Regular Off Off

This is a searchable database of information about tests offered by Severn Pathology. You can browse the index, enter a test name, part of a test name, abbreviation or clinical indication below.

The containers listed refer to those used to collect samples from adults locally in GP practices and hospital wards/outpatients. Details of the containers used for neonates, children and in the emergency zone (ED, AAU, ITU) can be found here Tube Guide and Recommended Order of Draw.

After performing a search for a specific test, the Reset button can be clicked to go back to the A-Z test list.

View
Special notes Tube type Sample type Test name Ideal volume Turnaround time Discipline
Special Precautions – Please click Test Name for further details 24 Serum 1,25-Dihydroxy Vitamin D 5 mL 4 weeks Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum 11-deoxycortisol 1 mL 1 week Clinical Biochemistry
Special Precautions – Please click Test Name for further details 20 Plasma 17 OHP 5 mL 14 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 31 Blood spot 17 OHP see notes 14 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 17 Plasma (fluoride oxalate) 3-Hydroxybutyrate 5 mL 7 days Clinical Biochemistry
24 Serum 5-Alpha Dihydrotestosterone 1 mL 28 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 2 Urine - 24 hour 5-HIAA n/a 7 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 20 Plasma 7-dehydrocholesterol 2 mL 28 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Whole blood ABO Antibody Titration for ABO Incompatible Renal Transplantation 8 ml 7 working days Immunology
24 Serum ACE 5 mL 7 days Clinical Biochemistry
34 CSF ACE 500 uL 6 weeks Clinical Biochemistry
24 Serum Acetylcholine Receptor Antibody 2 mL 3 weeks Immunology
Special Precautions – Please click Test Name for further details 24 Serum Aciclovir/CMMG <3 days Antimicrobial Reference Laboratory
Special Precautions – Please click Test Name for further details 14 Plasma ACTH 5 mL 5 days Clinical Biochemistry
9 Blood spot Acylcarnitines 1x Spot 21 days Clinical Biochemistry
20 Plasma Acylcarnitines 2 mL 21 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 13 Plasma ADAMTS13 48 hours Haematology
Special Precautions – Please click Test Name for further details 34 Fluid Adenosine Deaminase in TB 1 mL 14 days Clinical Biochemistry
34 Bronchoalveolar lavage (BALs) and Sputums Adenovirus
Molecular assay (NAAT)
500µL 2 days Virology
43 Swabs (nose and throat) Adenovirus
Molecular assay (NAAT)
500µL 2 days Virology
34 Nasopharayngeal aspirates (NPAs) Adenovirus
Molecular assay (NAAT)
500µL 2 days Virology
11 Faecal sample Adenovirus
PCR
pea sized amount 2 days Microbiology
43 Swab (eye) Adenovirus (qualitative)
PCR (In house)
500µl 3 days Virology
14 EDTA Blood sample Adenovirus (quantitative)
PCR (In house)
450µl 3 days Virology
24 Serum Adrenal Cortex Antibody 2 mL 14 working days Immunology
24 Serum AFP 5 mL 1 day Clinical Biochemistry
34 CSF AFP 2 mL 21 days Clinical Biochemistry
24 Fluid Albumin 5 mL 3 days Clinical Biochemistry
24 Serum Albumin 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
35 Urine - Random Albumin / creatinine ratio n/a 1 day Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Plasma Aldosterone 5 mL 21 days Clinical Biochemistry
24 Serum Alk Phos Isoenzymes 5 mL 7 days Clinical Biochemistry
24 Serum Allergen specific IgE 2 mL 7 working days Immunology
24 Serum ALP 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
24 Serum Alpha 1 antitrypsin activity 5 mL 3 days Immunology
24 Serum Alpha 1 antitrypsin phenotype 5 mL 14 working days Immunology
24 Serum Alpha subunit 2 mL 5 weeks Clinical Biochemistry
24 Serum ALT 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 10 Whole Blood Aluminium 5 mL 7 days Clinical Biochemistry
24 Serum AMH 2 mL 1 week Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Amikacin <1 day Antimicrobial Reference Laboratory
Special Precautions – Please click Test Name for further details 34 CSF Amino Acids CSF 1 mL 14 days Clinical Biochemistry
20 Plasma Amino Acids Plasma 2 mL 21 days Clinical Biochemistry
35 Urine - Random Amino Acids Urine 5 mL 21 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Plasma Amiodarone 5 mL 7 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Plasma Ammonia 1 mL 2 hours Clinical Biochemistry
24 Fluid Amylase 5 mL 3 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 35 Urine - Random Amylase 5 mL 4 hours Clinical Biochemistry
24 Serum ANCA 2 mL 4 working days Immunology
24 Serum Androstenedione 5 mL 28 days Clinical Biochemistry
24 Serum Anion Gap 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
16 Whole Blood Antenatal Blood Group and Antibody Screen 4 mL 1 day Blood Transfusion
24 Serum Anti Cardiolipin Antibody 2ml 1 week Immunology
24 Serum Anti PLA2 R 2ml 2 weeks Immunology
13 Whole Blood Anti Thrombin 3 full tubes 21 days Haematology
13 Plasma Anti-Xa 2.7 mL 24 hours Haematology
Special Precautions – Please click Test Name for further details 16 Whole Blood ANTIBODY Investigation (red cells) 6ml x 2 Up to 72 hours Blood Transfusion
24 Serum Antinuclear Antibody 2 mL 4 working days Immunology
Special Precautions – Please click Test Name for further details 14 Whole Blood Apo E genotyping 4 mL 28 days Genetics
24 Serum Apolipoprotein B 1 mL 1 week Clinical Biochemistry
13 Whole Blood APTT/APTT-R 2.7 mL 24 hours Haematology
Special Precautions – Please click Test Name for further details 14 Whole blood Arsenic 2 mL 2 weeks Clinical Biochemistry
Special Precautions – Please click Test Name for further details 34 Urine Arsenic (urine) 5 mL 2 weeks Clinical Biochemistry
Special Precautions – Please click Test Name for further details 25 Fluid Asialotransferrin see notes 3 working days Immunology
34 Broncheolar lavage (BAL) samples Aspergillus Antigen 700µL Mean 1 day Mycology Reference Laboratory
34 Broncheolar lavage (BAL) samples Aspergillus Antigen 700µL Mean 1 day Mycology Reference Laboratory
24 Clotted blood samples Aspergillus Antigen 700µL Mean 1 day Mycology Reference Laboratory
24 Clotted blood samples Aspergillus Antigen 700µL Mean 1 day Mycology Reference Laboratory
24 serum Aspergillus IgG 2ml 1 week Immunology
24 Clotted blood samples Aspergillus Precipitins 200µL Mean 3 days Mycology Reference Laboratory
24 Clotted blood samples Aspergillus Precipitins 200µL Mean 3 days Mycology Reference Laboratory
Special Precautions – Please click Test Name for further details 24 Serum AST 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
11 Faecal sample Astrovirus
PCR
pea sized amount 2 days Microbiology
24 Serum Autoimmune Liver Disease Antibodies 2 mL 4 working days Immunology
43 Swabs (nose and throat) Avian Influenza A PCR
Molecular assay (NAAT)
500µL 2 days Virology
24 Serum Avian proteins IgG 2ml 1 week Immunology
34 BAL MCS BAL MCS 3 mL 12 days Microbiology
Special Precautions – Please click Test Name for further details 35 Urine - Random Barbiturates 5 mL 3 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Benzylpenicillin (Penicillin G) <3 days Antimicrobial Reference Laboratory
24 Serum Beta 2 Glycoprotein 1 2 mL 7 working days Immunology
24 Serum Beta 2 microglobulin 2 mL 7 working days Immunology
24 Clotted blood samples Beta D Glucan 200µL Mean <1 day Mycology Reference Laboratory
24 Clotted blood samples Beta D Glucan 200µL Mean <1 day Mycology Reference Laboratory
24 Serum Bicarbonate 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
24 Serum Bilirubin 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details Plasma Bilirubin - infants 1 full paediatric lithium heparin tube 4 hours Clinical Biochemistry
24 Serum Bilirubin-(Conjugated fraction) 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 9 Blood spot Biopterins 6x Spots 28 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Plasma Biotinidase 1 mL 7 days Clinical Biochemistry
14 EDTA Blood sample BK virus (quantitative)
PCR (In house)
450µl 3 days Virology
34 Urine BK virus (quantitative)
PCR (In house)
500µl 3 days Virology
Special Precautions – Please click Test Name for further details 14 Whole Blood Blood Film 24 hours Haematology
Special Precautions – Please click Test Name for further details 18 Whole Blood Blood Gases see notes n/a Clinical Biochemistry
Special Precautions – Please click Test Name for further details Bone Marrow Bone Marrow Aspirate or Trephine Haematology
24 Serum Bone profile 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
43 Pernasal swabs Bordetella parapertussis
Molecular assay (NAAT)
500µL 3 days Virology
43 Pernasal swabs Bordetella pertussis
Molecular assay (NAAT)
500µL 3 days Virology
24 Clotted blood sample Bordetella pertussis antibodies
IgG
170µL 5 days Virology
24 Clotted blood sample Borrelia burgdorferi (Lyme) antibodies
IgG and IgM
380µL 4 days Virology
Special Precautions – Please click Test Name for further details 28 Urine - Random C-peptide : creatinine ratio 2 mL 1 week Clinical Biochemistry
14 Plasma C-Peptide (plasma) 5ml 1 week Clinical Biochemistry
11 Faeces C.difficile toxin 3 spoons/ pot should be at least 1/3 full 24 hours Microbiology
Special Precautions – Please click Test Name for further details 24 Serum C1 Esterase Inhibitor 2 mL 14 working days Immunology
Special Precautions – Please click Test Name for further details 14 Whole Blood C3 Degradation Products 3 mL 5 working days Immunology
24 Serum C3 Nephritic Factor 2 mL 7 working days Immunology
24 Serum CA 125 5 mL 1 day Clinical Biochemistry
24 Serum CA 15-3 5 mL 1 day Clinical Biochemistry
24 Serum CA 19-9 5 mL 1 day Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Whole Blood Cadmium 4 mL 14 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 35 Urine - Random Cadmium 5 mL 14 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Caeruloplasmin 5 mL 4 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Calcitonin 5 mL 14 days Clinical Biochemistry
4 Urine - 24 hour Calcium n/a 3 days Clinical Biochemistry
24 Serum Calcium 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 27 Serum and Urine Calcium excretion index 5 mL 3 days Clinical Biochemistry
11 Faeces Calprotectin 5 g 7 working days Immunology
24 Clotted blood samples Candida Antigen 300µL Mean 1.6 days Mycology Reference Laboratory
35 Urine - Random Cannabinoids 5 mL 3 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Carbamazepine 5 mL 1 day Clinical Biochemistry
Special Precautions – Please click Test Name for further details 18 Whole Blood Carboxyhaemoglobin full tube n/a Clinical Biochemistry
24 Serum Cardiac Muscle Antibody 2 mL 21 working days Immunology
Special Precautions – Please click Test Name for further details 35 Urine - Random Carnitine, 5 mL 14 days Clinical Biochemistry
Urine - 24 hour Catecholamines
14 Whole Blood CD 4 Counts 3 mL 1 working day Immunology
Special Precautions – Please click Test Name for further details 24 Serum CDT 5 mL 14 days Clinical Biochemistry
24 Serum CEA 5 mL 4 days (due to batching of the assay) Clinical Biochemistry
24 Serum Centromere Antibody 2 mL 7 working days Immunology
1 Aptima Swab Chlamydia trachomatis
NAAT
1 tube 3 days Virology
38 Aptima Urine Chlamydia trachomatis
NAAT
1 tube 3 days Virology
24 Clotted blood sample Chlamydia trachomatis antibodies
IgG
170µL 4 days Virology
1 Swab (eye) Chlamydia trachomatis/Neisseria gonorrhoeae
NAAT
1 tube 3 days Virology
37 See Notes Chlamydia/ GC other swabs n/a 10 days Microbiology
38 Urine - Random Chlamydia/ GC urine n/a 10 days Microbiology
1 See Notes Chlamydia/ GC vaginal swabs n/a 10 days Microbiology
Special Precautions – Please click Test Name for further details 24 Serum Chloramphenicol <3 days Antimicrobial Reference Laboratory
24 Serum Chloride 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
20 Plasma Cholestanol 1 mL 21 days Clinical Biochemistry
24 Serum Cholesterol 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
24 Fluid Cholesterol 2 mL 3 days Clinical Biochemistry
14 Whole Blood Cholinesterase Genotype 4 mL 10 - 12 weeks Clinical Biochemistry
14 EDTA (whole blood) Cholinesterase Studies 5 mL 3 - 4 weeks Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Whole Blood Chromium 4 mL 14 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Plasma Chromogranin A 5 mL 21 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Plasma Chromogranin B 5 mL 28 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Ciprofloxacin <3 days Antimicrobial Reference Laboratory
Special Precautions – Please click Test Name for further details 4 Urine - 24 hour Citrate n/a 7 days Clinical Biochemistry
20 Plasma Citrulline 1 mL Clinical Biochemistry
24 Serum CK 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
13 Whole Blood Clauss Fibrinogen 2.7 mL 24 hours Haematology
13 Whole Blood Clotting Screen 2.7 mL 24 hours Haematology
14 Plasma Clozapine Level 2.7 mL 10 days Haematology
34 Urine CMV
PCR (In house)
500µl 3 days Virology
24 Clotted blood sample CMV IgG CMV IgG and IgM 190µL, CMV IgG 170µL 4 days Virology
24 Clotted blood sample CMV IgM CMV IgG and IgM 190µL, CMV IgM 170µL 4 days Virology
Special Precautions – Please click Test Name for further details 14 Whole Blood Cobalt 4 mL 14 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Colistin <3 days
Antimicrobial Reference Laboratory
24 Serum Complement C3 + C4 2 mL 4 working days Immunology
Special Precautions – Please click Test Name for further details 24 Serum Complement Function 5 mL 28 working days Immunology
Special Precautions – Please click Test Name for further details 24 Serum Copeptin 5 mL 14 days Clinical Biochemistry
24 Serum Copper 5 mL 7 days Clinical Biochemistry
5 Urine - 24 hour Copper n/a 7 days Clinical Biochemistry
24 Serum Cortisol 5 mL 1 day Clinical Biochemistry
34 Nasopharayngeal aspirates (NPAs) COVID-19
Molecular assay (NAAT)
500µL 1 day Virology
34 Bronchoalveolar lavage (BALs) and Sputums COVID-19
Molecular assay (NAAT)
500µL 1 day Virology
43 Swabs (nose and throat) COVID-19
Molecular assay (NAAT)
500µL 1 day Virology
Special Precautions – Please click Test Name for further details 35 Urine - Random Creatine Studies 5 mL 14 days Clinical Biochemistry
20 Plasma Creatine Studies 2 mL 21 days Clinical Biochemistry
34 Dialysate Creatinine 2 mL 1 day Clinical Biochemistry
24 Fluid Creatinine 2 mL 3 days Clinical Biochemistry
24 Serum Creatinine 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 26 Serum and Urine Creatinine clearance n/a 8 hours Clinical Biochemistry
24 Serum Crithidia for dsDNA antibodies 2ml 14 working days Immunology
Special Precautions – Please click Test Name for further details 19 Whole Blood Crossmatch - (Lymphocyte) for Renal Transplantation Immunology see notes See notes Immunology
Special Precautions – Please click Test Name for further details 16 Whole Blood Crossmatch - Blood Transfusion 4 mL See Notes Blood Transfusion
24 Serum CRP 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Cryoglobulin see notes 10 working days Immunology
Special Precautions – Please click Test Name for further details CSF CSF neurodegenerative markers 0.5mL in each tube 10 working days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Plasma CTx 2 mL 21 days Clinical Biochemistry
24 Serum Cyclic Citrullinated Peptide Antibodies 2 mL 14 working days Immunology
Special Precautions – Please click Test Name for further details 24 Serum Cycloserine <3 days Antimicrobial Reference Laboratory
Special Precautions – Please click Test Name for further details 14 Whole Blood Cyclosporin 4 mL 3 days Clinical Biochemistry
24 Serum Cystatin C 2mL 7 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 4 Urine - 24 hour Cystine 24 hour excretion n/a 21 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 33 Urine - timed Cystine day/night n/a 21 days Clinical Biochemistry
35 Urine - Random Cystine Random Urine 5 mL 21 days Clinical Biochemistry
34 CSF Cytomegalovirus CMV (quantitative)
PCR (In house)
200µl 3 days Virology
34 Amniotic fluid Cytomegalovirus CMV (quantitative)
PCR (In house)
200µl 3 days Virology
14 EDTA Blood sample Cytomegalovirus CMV (quantitative)
PCR (In house)
450µl 3 days Virology
34 Nasopharayngeal aspirates (NPAs) Cytomegalovirus CMV(qualitative)
PCR (In house)
500µL 3 days Virology
24 Clotted blood sample Cytomegalovirus IgG avidity 170µL 4 days Virology
34 Bronchoalveolar lavage (BALs) and Sputums Cytomegaloviurs CMV (qualitative)
PCR (In house)
500µL 3 days Virology
13 Whole Blood D-Dimer 2.7 mL 24 hours Haematology
Special Precautions – Please click Test Name for further details 24 Serum Daptomycin <3 days Antimicrobial Reference Laboratory
14 Whole Blood DAT 3 mL 24 hours Blood Transfusion
Special Precautions – Please click Test Name for further details 24 Serum DHEAS 5 mL 10 days Clinical Biochemistry
24 Serum Diabetes Autoantibodies (ZnT8, GAD, IA2) 2 mL 28 working days Immunology
Special Precautions – Please click Test Name for further details 24 Serum Digoxin 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
24 Serum Down's Syndrome Screening 5 mL 7 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 35 Urine - Random Drug (Overdose) Screen 5 mL 3 days Clinical Biochemistry
35 Urine - Random Drugs of Abuse 5 mL 4 days Clinical Biochemistry
24 Serum ds-DNA antibodies 2 mL 7 working days Immunology
14 EDTA Blood sample EBV (quantitative)
PCR (In house)
450µl 3 days Virology
24 Serum eGFR 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
24 Fluid Electrolytes 2 mL 3 days Clinical Biochemistry
24 Serum ELF 5 mL 10 days Clinical Biochemistry
24 Serum Endomysium Antibody 2 mL Immunology
43 Vesicle swab Enterovirus
PCR (In house)
500µl 3 days Virology
34 CSF Enterovirus
PCR (In house)
200µl 3 days Virology
43 Swabs Throat swab Enterovirus
PCR (In house)
500µL 3 days Virology
14 EDTA Blood sample Enterovirus
PCR (In house)
450µl 3 days Virology
34 Vesicle fluid Enterovirus
PCR (In house)
500µl 3 days Virology
43 Vesicle Swab Enterovirus
PCR (In house)
500µl Virology
11 Faecal sample Enterovirus
PCR (In house)
pea sized amount 3 days Virology
24 Whole Blood EPO 5 mL 10 days Clinical Biochemistry
24 Clotted blood sample Epstein Barr Virus (EBV) IgG 170µL 4 days Virology
24 Clotted blood sample Epstein Barr Virus (EBV) serology
EBNA VCA IgG and IgM
420µL 4 days Virology
34 CSF Epstein Barr Virus EBV (qualitative)
PCR (In house)
200µl 3 days Virology
Special Precautions – Please click Test Name for further details 24 Serum Ethambutol <3 days
Antimicrobial Reference Laboratory
35 Urine - Random Ethanol 2 mL 1 day Clinical Biochemistry
Special Precautions – Please click Test Name for further details 17 Plasma Ethanol 5 mL 4 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 17 Plasma Ethylene glycol 5 mL 1 day Clinical Biochemistry
24 Serum Extractable Nuclear Antigen 2 mL 7 working days Immunology
Special Precautions – Please click Test Name for further details 14 Whole Blood Fabry Screen 4 mL 2-3 weeks Clinical Biochemistry
13 Plasma Factor II 2 full tubes 2 weeks Haematology
13 Whole Blood Factor IX Assay 2.7 mL 10 days Haematology
13 Plasma Factor V 2 full tubes 2 weeks Haematology
13 Whole Blood Factor V Leiden 2.7 mL 1 month Haematology
13 Plasma Factor VII 2 full tubes 2 weeks Haematology
13 Whole Blood Factor VIII Assay 2.7 mL 10 days Haematology
Special Precautions – Please click Test Name for further details 13 Plasma Factor VIII Inhibitor 2 full tubes 2 weeks, urgents will be processed as required following discussion with Haematologist Haematology
13 Plasma Factor X 2 full tubes 10 days Haematology
13 Plasma Factor XI 2 full tubes 10 days Haematology
13 Plasma Factor XII 2 full tubes 10 days Haematology
13 Plasma Factor XIII 2 full tubes 10 days Haematology
11 Faeces Faecal Elastase 5 g 16 working days Immunology
Faecal reducing substances
Fat Globules
24 Serum Ferritin 5 mL 24 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Plasma FGF-23 2 mL 4 weeks Clinical Biochemistry
24 Plasma AND Serum FIB-4 5 mL 24 hours Clinical Biochemistry
Faecal FIT 2 working days Immunology
Special Precautions – Please click Test Name for further details 24 Serum Flucloxacillin <3 days Antimicrobial Reference Laboratory
Special Precautions – Please click Test Name for further details Serum Fluconazole < 2 days Antimicrobial Reference Laboratory
Special Precautions – Please click Test Name for further details Serum Flucytosine < 2 days Antimicrobial Reference Laboratory
Special Precautions – Please click Test Name for further details 16 Whole Blood Foetal leak investigation 4 mL 1 day Blood Transfusion
24 Serum Folate 5 mL 24 hours Clinical Biochemistry
24 Serum Free androgen index 5 mL 7 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 17 Plasma (fluoride oxalate) Free Fatty Acids 2 mL 7 days Clinical Biochemistry
16 Whole Blood Free fetal DNA for fetal Rh typing 4 mL 15 days Blood Transfusion
Special Precautions – Please click Test Name for further details 24 Serum Free Light Chains 2 mL 7 working days Immunology
Special Precautions – Please click Test Name for further details 24 Serum Free Testosterone 5 mL 7 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Fructosamine 5 mL 7 days Clinical Biochemistry
24 Serum FSH 5 mL 1 day Clinical Biochemistry
14 Whole Blood Full Blood Count 4 mL 24 hours Haematology
35 Urine - Random Galactitol 5 mL 28 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 20 Whole Blood Galactokinase 1 mL 14 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 20 Whole Blood Galactosaemia screen 1 mL 7 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 20 Whole Blood Galactose-1-phosphate 0.5 mL 28 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 20 Whole Blood Galactose-1-phosphate uridyl transferase (quantitative) 1 mL 28 days Clinical Biochemistry
24 Serum Gamma GT 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Ganciclovir <3 days Antimicrobial Reference Laboratory
24 Serum Ganglioside Antibodies 2 mL 21 working days Immunology
24 Serum Gastric Parietal Cell Antibody 2 mL 4 working days Immunology
Special Precautions – Please click Test Name for further details 14 Plasma Gastrin 5 mL 28 days Clinical Biochemistry
24 Serum GBM Antibody 2 mL 7 working days Immunology
Special Precautions – Please click Test Name for further details 24 Serum Gentamicin 5mL Hospital patients 4 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Plasma Glucagon 5 mL 28 days Clinical Biochemistry
17 Fluid Glucose 2 mL 3 days Clinical Biochemistry
17 CSF Glucose 2 mL 4 hours Clinical Biochemistry
24 Serum Glucose (inpatients only) 5 mL 4 hours Clinical Biochemistry
17 Plasma Glucose (outpatients/General practice) 2 mL 1 day Clinical Biochemistry
14 Whole Blood Glucose 6 Phosphate Dehydrogenase 4 mL 5 working days, 10 working days if sent to referral laboratory for quantitative testing Haematology
17 Plasma Glucose tolerance test 2 mL 8 hours Clinical Biochemistry
17 Plasma Glucose tolerance test in Pregnancy 2 mL 1 day Clinical Biochemistry
16 Whole Blood Group and Hold 4 mL 24 hours Blood Transfusion
Special Precautions – Please click Test Name for further details 24 Serum Growth Hormone 5 mL 7 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Plasma Gut Hormones 10 mL 28 days Clinical Biochemistry
11 Faeces H.pylori 1/3 full/10ml minimum 3 days Microbiology
14 Whole Blood Haematocrit 4 mL 24 hours Haematology
14 Whole Blood Haemoglobin 4 mL 24 hours Haematology
14 Whole Blood Haemoglobinopathy screen 4 mL 3 days Haematology
34 Urine - Random and Bone Marrow Haemosiderin 2 mL 7 days Haematology
24 Serum Haptoglobin 5 mL 7 working days Clinical Biochemistry
14 Whole Blood HbA1c 4 mL 3 working days Haematology
34 CSF hCG 2 mL 21 days Clinical Biochemistry
24 Serum hCG 5 mL 1 day (2 hours for urgent requests) Clinical Biochemistry
See Notes hCG (Molar) Clinical Biochemistry
24 Serum HDL Cholesterol 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
24 Clotted blood sample Helicobacter pylori antibodies
IgG
160µL 4 days Virology
24 Clotted blood sample Hepatitis A
IgM and IgG
Anti-HAV 240µL HAVIgM 170µL 3 days Virology
14 EDTA Blood sample Hepatitis B (quantitative)
Molecular assay
1mL 5 days Virology
24 Clotted blood sample Hepatitis B Surface Antibody Anti-HBs (Quantitative) 300µL 3 days Virology
24 Clotted blood sample Hepatitis B Surface Antigen (HBsAG) 500µL 3 days - Screen 7 days - Confirmations Virology
14 EDTA Blood sample Hepatitis C (genotype)
PCR (In house)
200µl 14 days Virology
14 EDTA Blood sample Hepatitis C (quantitative)
PCR (In house)
1mL 5 days Virology
24 Clotted blood sample Hepatitis C antibody
Total antibody screening & confirmation testing
500µL 3 days - Screen 7 days - Confirmations Virology
24 Clotted blood sample Hepatitis E
IgM & IgG
500µL 4 days Virology
24 Clotted blood sample Hepatits B core antibody 260µL 3 days Virology
43 Swab (eye) Herpes simplex HSV 1 and 2
PCR (In house)
500µl 3 days Virology
34 CSF Herpes Simplex HSV 1 and 2
PCR (In house)
200µl 3 days Virology
43 Vesicle Swab Herpes simplex HSV 1 and 2
PCR (In house)
500µl Virology
24 Clotted blood samples Herpes Simplex HSV 1 and 2 specific serology
IgG
190µL 4 days Virology
14 EDTA blood sample Herpes Simplex HSV 1and 2
PCR (In house)
450µl 3 days Virology
14 EDTA (whole blood) HGA - HFE Gene Analysis 1-5 ml Genetics (Exeter lab)
14 EDTA Blood sample HHV6 - Blood
PCR (In house)
450µl 3 days Virology
34 CSF HHV6 - CSF
PCR
450µl 3 days Virology
24 Serum Histone antibodies 2 mL 21 working days Immunology
Special Precautions – Please click Test Name for further details 24 Clotted blood HIT 1 day for urgent requests otherwise 5 days. Haematology
14 EDTA Blood sample HIV (quantitative)
Molecular assay
1mL 7 days Virology
24 Clotted blood sample HIV 1 and 2 antigen/antibody
Confirmation
500µL 7 days - Confirmations Virology
24 Clotted blood sample HIV 1 and 2 antigen/antibody
Total antibody/antigen
350µL 3 days - Screen 4 days - confirmations Virology
24 Serum HLA antibody screen 2 mL 14 working days Immunology
15 Whole Blood HLA type (DR,DQ,DP)Class II 8 mL 28 working days Immunology
15 Whole Blood HLA type(A,B,C)Class I 8 mL 28 working days Immunology
14 Whole Blood HLA-A29 3 mL 14 working days Immunology
14 Whole Blood HLA-B27 3 mL 14 working days Immunology
14 Whole Blood HLA-B51(5) 3 mL 14 working days Immunology
14 Whole Blood HLA-B57(B*57:01) 3 mL 10 working days Immunology
14 Whole Blood HLA-DQ2+DQ8(3) 3 mL 14 working days Immunology
14 Whole Blood HLA-DR15(2) DQ6(DQB1*06:02) 3 mL 14 working days Immunology
Special Precautions – Please click Test Name for further details 14 Plasma Homocysteine (Total) 2 mL 7 days Clinical Biochemistry
24 Clotted blood sample HTLV antibody
Total Antibody screening
250µL 3 days Virology
34 Bronchoalveolar lavage (BALs) and Sputums Human metapneumovirus
Molecular assay (NAAT)
500µL 2 days Virology
34 Nasopharayngeal aspirates (NPAs) Human metapneumovirus
Molecular assay (NAAT)
500µL 2 days Virology
43 Swabs (nose and throat) Human metapneumovirus
Molecular assay (NAAT)
500µL 2 days Virology
35 Urine - Random HVA 5 mL 7 days Clinical Biochemistry
24 Serum IgE 2 mL 7 working days Immunology
24 Serum IGF-1 5 mL 5 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum IGFBP-3 5 mL 14 days Clinical Biochemistry
24 Serum IgG Subclasses 2 mL 7 working days Immunology
14 Whole Blood Immunodeficiency (Immunophenotyping) 3 mL 2 working days Immunology
Special Precautions – Please click Test Name for further details n/a Immunodeficiency Investigations Immunology
24 Serum Immunoglobulins 2 mL 3 working days Immunology
7 Various Infection screen Carbapenemase screen (rectal swab) n/a 3 days Microbiology
Various Infection screen MRC Screening (Burns) n/a 3 days Microbiology
Various Infection screen MRSA Screen n/a 3 days Microbiology
Various Infection screen MSSA Screening (Renal/ Spinal) n/a 3 days Microbiology
7 Various Infection screen Pseudomonas Screening (NICU) n/a 2 days Microbiology
14 Plasma Infectious Mononucleosis 3 mL 72 hours Haematology
43 Swabs (nose and throat) Influenza A Virus
Molecular assay (NAAT)
500µL 2 days Virology
34 Nasopharayngeal aspirates (NPAs) Influenza A Virus
Molecular assay (NAAT)
500µL 2 days Virology
34 Bronchoalveolar lavage (BALs) and Sputums Influenza A virus Molecular assay (NAAT) 500µL 2 days Virology
43 Swabs (nose and throat) Influenza B Virus
Molecular assay (NAAT)
500µL 2 days Virology
34 Bronchoalveolar lavage (BALs) and Sputums Influenza B virus
Molecular assay (NAAT)
500µL 2 days Virology
34 Nasopharayngeal aspirates (NPAs) Influenza B Virus
Molecular assay (NAAT)
500µL 2 days Virology
13 Whole Blood INR 2.7 mL 24 hours Haematology
Special Precautions – Please click Test Name for further details 44 Plasma Insulin (Paediatric) 1 mL 1 working day Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Insulin and C-peptide 5 mL 14 days Clinical Biochemistry
24 Serum Intrinsic Factor Antibodies 5 mL 10 days Clinical Biochemistry
24 Serum Iohexol GFR 2ml 7 days Clinical Biochemistry
24 Serum Iron 5 mL <4 hours Clinical Biochemistry
24 Serum Iron and Transferrin Saturation 5 mL 1 day Clinical Biochemistry
Special Precautions – Please click Test Name for further details Serum Isavuconazole < 2 days Antimicrobial Reference Laboratory
14 Whole Blood Isoelectric focusing for determining Abnormal Haemoglobins 14 days Haematology
17 Whole Blood Collected in Fluoride Oxalate (Fx) Tube Isoniazid (+ N-Acetyl-Isoniazid) 1-2 ml <3 days (from day of receipt) Antimicrobial Reference Laboratory
Special Precautions – Please click Test Name for further details n/a Issue of Albumin Solution n/a Blood Transfusion
Special Precautions – Please click Test Name for further details n/a Issue of Fresh Frozen Plasma n/a Blood Transfusion
Special Precautions – Please click Test Name for further details n/a Issue of Platelets n/a Blood Transfusion
Special Precautions – Please click Test Name for further details Serum Itraconazole < 2 days Antimicrobial Reference Laboratory
Special Precautions – Please click Test Name for further details 35 Urine - Random Ketones 5 mL n/a Clinical Biochemistry
17 CSF Lactate 2 mL 4 hours Clinical Biochemistry
17 Plasma Lactate (Laboratory analysis)   2 mL 4 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 18 Whole Blood Lactate (Point of Care Testing) n/a n/a Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Plasma Lamotrigine 5 mL 1 - 2 weeks Clinical Biochemistry
34 CSF LDH 0.5 mL 1 day Clinical Biochemistry
24 Serum LDH 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
24 Fluid LDH 2 mL 3 days Clinical Biochemistry
24 Serum LDL Cholesterol 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
14 Whole Blood Lead 1 mL 7 days Clinical Biochemistry
35 Urine - Random Lead 5 mL 7 days Clinical Biochemistry
34 Urine Legionella antigen 3 mL 1 day Microbiology
14 Bone Marrow Leukaemial/Lymphoma Immunophenotyping 0.5 mL 1 working day Immunology
Special Precautions – Please click Test Name for further details 34 Lymph Nodes Leukaemial/Lymphoma Immunophenotyping see notes 1 working day Immunology
Special Precautions – Please click Test Name for further details 34 Other fluids Leukaemial/Lymphoma Immunophenotyping see notes 1 working day Immunology
14 Whole Blood Leukaemial/Lymphoma Immunophenotyping 3 mL 1 working day Immunology
Special Precautions – Please click Test Name for further details 20 Whole Blood Leukocyte Cystine 4 mL 28 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Levofloxacin <3 days Antimicrobial Reference Laboratory
24 Serum LFT 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
24 Serum LH 5 mL 1 day Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Linezolid <3 days Antimicrobial Reference Laboratory
24 Serum Lipase 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
24 Serum Lipid Profile 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Lipoprotein (a) 5 mL 21 days Clinical Biochemistry
24 Serum Lipoprotein Electrophoresis 5 mL 14 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Lithium 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
24 Serum Liver Kidney Microsomal 2 mL 4 working days Immunology
24 Serum Liver line blot 2ml 2 weeks Immunology
Special Precautions – Please click Test Name for further details 13 Whole Blood Lupus Anticoagulant 3 full tubes 10 days Haematology
Special Precautions – Please click Test Name for further details 20 Whole Blood Lymphocyte Function Tests 7 mL 7 working days Immunology
Special Precautions – Please click Test Name for further details 24 Serum Macro CK 5 mL 4-6 weeks Clinical Biochemistry
24 Serum Macroprolactin 5 mL 14 days Clinical Biochemistry
24 Serum Macroprolactin confirmation 2 mL 3 weeks Clinical Biochemistry
4 Urine - 24 hour Magnesium n/a 3 days Clinical Biochemistry
24 Serum Magnesium 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Whole Blood Malaria Parasites 4 mL 24 hours, 7 working days if sent to Referral Laboratory for confirmation Haematology
Special Precautions – Please click Test Name for further details 10 Whole Blood Manganese 5 mL 14 days Clinical Biochemistry
24 Serum Mannose Binding Lectin 2 mL 14 working days Immunology
Special Precautions – Please click Test Name for further details 14 Whole Blood Manual Blood Film including White Cell differential 24 hours Haematology
Special Precautions – Please click Test Name for further details 24 Serum Mast Cell Tryptase 2 mL 9 working days Immunology
14 Whole Blood MCH 4 mL 24 hours Haematology
14 Whole Blood MCHC 4 mL 24 hours Haematology
8 Whole Blood MCS (Blood Culture) Adults: 8-10mL blood per blood culture bottle; Paeds: 1-3mL blood. Wherever possible, please ensure that each bottle of the blood culture set is inoculated with the correct volume of blood. Smaller volumes adversely affect the sensitivity of the assay. 6 days Microbiology
34 CSF MCS (Cerebrospinal fluid) 3 mL 4 days Microbiology
Corneal Scrapes MCS (Corneal Scrapes) 10 days Microbiology
7 Swab MCS (Ear / left / right) n/a 4 days Microbiology
7 Swab MCS (Eye / left / right) n/a 4 days Microbiology
Special Precautions – Please click Test Name for further details 11 Faeces MCS (Faeces) 1/3 full/10ml minimum 4 days Microbiology
34 Fluid MCS (Fluids) 3 mL 7 days Microbiology
7 Swab MCS (Genital Swabs) n/a 4 days Microbiology
7 Mouth MCS (Mouth Swab) n/a 4 days Microbiology
7 MCS (Nose swab) n/a 4 days Microbiology
7 Penile  MCS (Penile swab) n/a 4 days Microbiology
34 Peritoneal fluid MCS (Peritoneal Dialysis fluid) n/a 6 days Microbiology
34 Pus MCS (Pus) n/a 8 days Microbiology
7 Swab MCS (Skin swab) n/a 4 days Microbiology
34 Sputum MCS (Sputum) n/a 4 days Microbiology
7 Swab MCS (Throat swab) n/a 4 days Microbiology
34 Tip MCS (Tip) n/a 4 days Microbiology
34 Tissue MCS (Tissues) n/a 10 days Microbiology
34 Trachael aspirate MCS (Tracheal aspirate) n/a 4 days Microbiology
21 Swab MCS (Urethral swab) n/a 4 days Microbiology
28 Urine MCS (Urine Catheter) > 3 ml 3 days Microbiology
28 Urine MCS (Urine) > 3 ml 3 days Microbiology
7 Swab MCS (Wound Swab) n/a 4 days Microbiology
14 Whole Blood MCV 4 mL 24 hours Haematology
24 Clotted blood sample Measles IgG 170µL 4 days Virology
24 Clotted blood samples Measles IgG and IgM 190µL 4 days Virology
43 Swabs (nose and throat) Measles PCR
PCR (In house)
500µL 3 days Virology
Special Precautions – Please click Test Name for further details 14 Whole Blood Mercury 1 mL 14 days Clinical Biochemistry
35 Urine - Random Mercury 1 mL 14 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Meropenem <3 days Antimicrobial Reference Laboratory
43 Swabs (nose and throat) MERS-CoV
Molecular assay (NAAT)
500µL 1 day Virology
Special Precautions – Please click Test Name for further details 24 Serum Mesothelin 2 ml Please note this test is not currently available. For further information or enquires please contact the Immunology laboratory 0117 4148366 Immunology
Special Precautions – Please click Test Name for further details 4 Urine - 24 hour Metadrenalines n/a 7 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Whole Blood Metadrenalines (Plasma) 4 mL 2 weeks Clinical Biochemistry
17 Plasma Methanol 5 mL 1 day Clinical Biochemistry
34 Tissue - e.g. lung biopsy, corneal scraping Microscopy and Culture Microscopy mean 1 day Mycology Reference Laboratory
34 Bronchoalveolar lavage (BALs) and Sputums Microscopy and Culture 300µL Microscopy mean 1 day Mycology Reference Laboratory
34 Bronchoalveolar lavage (BALs) and Sputums Microscopy and Culture 300µL Microscopy mean 1 day Mycology Reference Laboratory
34 Fluids - e.g. CSF, vitreous Microscopy and Culture 200µL Microscopy mean 1 day Mycology Reference Laboratory
34 Fluids - e.g. CSF, vitreous Microscopy and Culture 200µL Microscopy mean 1 day Mycology Reference Laboratory
34 Tissue - e.g. lung biopsy, corneal scraping Microscopy and Culture Microscopy mean 1 day Mycology Reference Laboratory
Microscopy for Crystals Cytology
24 Serum Mitochondrial antibody 2 mL 4 working days Immunology
35 Urine - Random MMA 5 mL 28 days Clinical Biochemistry
24 Serum MMA 2 mL 20 days Clinical Biochemistry
43 Swabs (nose and throat) Molecular assay (NAAT) Biofire Film array RP2 500µL 2 days Virology
Special Precautions – Please click Test Name for further details 24 Serum Moxifloxacin <3 days Antimicrobial Reference Laboratory
14 Bone Marrow MRD Flow Cytometry 0.5 mL 1 working day Immunology
35 Urine - Random Mucopolysaccharide screen 5 mL 14 days Clinical Biochemistry
24 Clotted blood sample Mumps IgG 170µL 4 days Virology
23 Hair Mycology Hair n/a 15 days Microbiology
23 Nail clippings Mycology Nail n/a 15 days Microbiology
23 Skin & nail Mycology Scrapings (skin and nail) n/a 15 days Microbiology
Special Precautions – Please click Test Name for further details 14 Whole Blood Mycophenolate 4 mL 14 days Clinical Biochemistry
45 Aptima Swab or urine with a Copan or virocult swab Mycoplasma Genitalium 1 tube 3 days Virology
43 Swabs (nose and throat) Mycoplasma pneumoniae
Molecular assay (NAAT) Biofire Film array
500µL 2 days Virology
Myoglobin - Urine
24 Serum Myositis line blot 2ml 2 weeks Immunology
34 Urine - Random NAG: Creatinine ratio                        1 mL 4 weeks Clinical Biochemistry
38 Aptima Urine Neisseria gonorrhoeae
NAAT
1 tube 3 days Virology
1 Aptima Swab Neisseria gonorrhoeae
NAAT
1 tube 3 days Virology
44 Whole Blood Neonatal Blood Group 1 mL 24 hours Blood Transfusion
44 Whole Blood Neonatal Crossmatch - Blood Transfusion 1 mL See Notes Blood Transfusion
44 Whole Blood Neonatal DAT 1 mL 24 hours Blood Transfusion
Special Precautions – Please click Test Name for further details 24 Serum Neuron Specific Enolase 5 mL 3 days Clinical Biochemistry
24 Serum Neuronal Antibody (Purkinje) 2 mL 14 working days Immunology
Special Precautions – Please click Test Name for further details 14 Plasma Neurotensin 5 mL 28 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 32 CSF Neurotransmitters see notes 4 - 6 weeks Clinical Biochemistry
Special Precautions – Please click Test Name for further details 20 Whole Blood Neutrophil Function Tests 7 mL 2 working days Immunology
9 Blood spot Newborn Screen 4x Spots Clinical Biochemistry
11 Faecal sample Norovirus PCR
pea sized amount 2 days Microbiology
24 Serum NT-Pro-BNP 5 mL 1 day Clinical Biochemistry
24 Serum Oestradiol 5 mL 1 day Clinical Biochemistry
Special Precautions – Please click Test Name for further details 25 Serum and CSF Oligoclonal bands 50ul CSF, 50ul Serum 5 working days Immunology
34 CSF Orexin 2mL 42 days Clinical Biochemistry
35 Urine - Random Organic acids 5 mL 14 days Clinical Biochemistry
35 Urine - Random Orotic acid 5 mL 14 days Clinical Biochemistry
35 Urine - Random Osmolality 5 mL Hospital patients 8 hours; GP patients 24 hours Clinical Biochemistry
24 Serum Osmolality 5 mL Hospital patients 8 hours; GP patients 24 hours Clinical Biochemistry
11 Faeces/ Urine Ova Cysts & Parasites Faeces/ Urine - Concentrate Minimum volume: 1/3 full/10ml minimum 4 days Microbiology
24 Serum Ovarian Antibody 2 mL 21 working days Immunology
Special Precautions – Please click Test Name for further details 14 Plasma Oxalate 5 mL 14 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 4 Urine - 24 hour Oxalate n/a 7 days Clinical Biochemistry
24 Serum Pancreatic Islet Cell Antibody 2 mL 14 working days Immunology
Special Precautions – Please click Test Name for further details 14 Plasma Pancreatic Polypeptide 5 mL 28 days Clinical Biochemistry
24 Serum Paracetamol 5 mL 4 hours Clinical Biochemistry
34 Nasopharayngeal aspirates (NPAs) Paraflu 1
Molecular assay (NAAT)
500µL 2 days Virology
34 Bronchoalveolar lavage (BALs) and Sputums Paraflu 1
Molecular assay (NAAT)
500µL 2 days Virology
34 Bronchoalveolar lavage (BALs) and Sputums Paraflu 2
Molecular assay (NAAT)
500µL 2 days Virology
34 Nasopharayngeal aspirates (NPAs) Paraflu 2
Molecular assay (NAAT)
500µL 2 days Virology
43 Swabs (nose and throat) Paraflu 2
Molecular assay (NAAT)
500µL 2 days Virology
34 Bronchoalveolar lavage (BALs) and Sputums Paraflu 3
Molecular assay (NAAT)
500µL 2 days Virology
34 Nasopharayngeal aspirates (NPAs) Paraflu 3
Molecular assay (NAAT)
500µL 2 days Virology
43 Swabs (nose and throat) Paraflu 3
Molecular assay (NAAT)
500µL 2 days Virology
43 Swabs (nose and throat) Paraflu 4
Molecular assay (NAAT)
500µL 2 days Virology
34 Nasopharayngeal aspirates (NPAs) Paraflu 4
Molecular assay (NAAT)
500µL 2 days Virology
34 Bronchoalveolar lavage (BALs) and Sputums Paraflu 4
Molecular assay (NAAT)
500µL 2 days Virology
43 Swabs (nose and throat) Paraflu1
Molecular assay (NAAT)
500µL 2 days Virology
24 Serum Paraneoplastic line blot 2ml 2 weeks Immunology
35 Urine - Random Paraquat 5 mL 2 days Clinical Biochemistry
14 EDTA Blood sample Parvovirus
PCR (In house)
450µl 3 days Virology
34 Amniotic fluid Parvovirus
PCR (In house)
200µl 3 days Virology
24 Clotted blood samples Parvovirus IgG and IgM Parvovirus IgG 170µL, Parvovirus IgG and IgM 190µL 4 days Virology
22 Swab Pernasal swab (Bordetella/Whooping cough) n/a 8 days Microbiology
Special Precautions – Please click Test Name for further details 24 Serum Phenobarbitone 5 mL 1 day Clinical Biochemistry
9 Blood spot Phenylalanine 2x Spots 5 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Phenytoin 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
4 Urine - 24 hour Phosphate n/a 3 days Clinical Biochemistry
24 Serum Phosphate 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
20 Plasma Phytanic acid 2 mL 21 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum PIIINP 2 mL 4-6 weeks Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Piperacillin <3 days Antimicrobial Reference Laboratory
Special Precautions – Please click Test Name for further details 13 Plasma PIVKA II 10 days Haematology
14 Whole Blood Plasma Viscosity 4 mL 3 days Haematology
14 Whole Blood Platelet count (EDTA & Citrate) 4 mL 24 hours Haematology
34 Urine Pneumococcal antigen 3 mL 1 day Microbiology
14 See Notes PNH Immunophenotyping 3 mL 4 working days Immunology
Special Precautions – Please click Test Name for further details 14 Whole Blood Porphyrin Enzyme/DNA analysis 4 mL 28 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Whole Blood Porphyrins 5-10 mL 15 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 11 Faeces Porphyrins 5 g 15 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 34 Urine - Random Porphyrins 10 mL 15 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details Serum Posaconazole < 2 days Antimicrobial Reference Laboratory
5 Urine Potassium n/a 1 day Clinical Biochemistry
24 Serum Potassium 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
24 Serum Prednisolone 5 mL 21 days Clinical Biochemistry
24 Serum Progesterone 5 mL 1 day Clinical Biochemistry
24 Serum Prolactin 5 mL 1 day Clinical Biochemistry
24 Fluid Protein 5 mL 3 days Clinical Biochemistry
35 Urine - Random Protein 5 mL 1 day Clinical Biochemistry
34 CSF Protein 2 mL 4 hours Clinical Biochemistry
34 Dialysate Protein 5 mL 8 hours Clinical Biochemistry
24 Serum Protein 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
13 Whole Blood Protein C 3 full tubes 21 days Haematology
13 Whole Blood Protein S 3 full tubes 21 days Haematology
13 Whole Blood Prothrombin Gene Mutation 3 full tubes 1 month Haematology
24 Serum PSA 5 mL 1 day Clinical Biochemistry
14 Plasma PTH 5 mL 1 day Clinical Biochemistry
32 PTH-related peptide Clinical Biochemistry
Special Precautions – Please click Test Name for further details 35 Urine - Random Purine / Pyrimidine Screen 5 mL 21 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Plasma Pyruvate Kinase 21 days Haematology
Special Precautions – Please click Test Name for further details 32 See Notes Quantiferon 7 working days Immunology
24 Serum RAST 2 mL Immunology
14 Whole Blood Red Blood Count 4 mL 24 hours Haematology
Red cell Transketolase
14 Plasma Renin 5 mL 28 days Clinical Biochemistry
34 Nasopharayngeal aspirates (NPAs) Respiratory syncytial virus
Molecular assay (NAAT)
500µL 2 days Virology
34 Bronchoalveolar lavage (BALs) and Sputums Respiratory Syncytial Virus
Molecular assay (NAAT)
500µL 2 days Virology
43 Swabs (nose and throat) Respiratory Syncytial Virus
Molecular assay (NAAT)
500µL 2 days Virology
14 Whole Blood Reticulocytes 4 mL 24 hours Haematology
Special Precautions – Please click Test Name for further details 34 Urine - Random Retinol Binding Protein 20 mL 14 days Clinical Biochemistry
24 Serum Rheumatoid Factor 2 mL 3 working days Immunology
43 Swabs (nose and throat) Rhinovirus
Molecular assay (NAAT)
500µL 2 days Virology
34 Bronchoalveolar lavage (BALs) and Sputums Rhinovirus
Molecular assay (NAAT)
500µL 2 days Virology
34 Nasopharayngeal aspirates (NPAs) Rhinoviurs
Molecular assay (NAAT)
500µL 2 days Virology
Special Precautions – Please click Test Name for further details 24 Serum Rifabutin <3 days Antimicrobial Reference Laboratory
Special Precautions – Please click Test Name for further details 24 Serum Rifampicin <3 days Antimicrobial Reference Laboratory
13 Whole Blood Ristocetin Co Factor. 2.7 mL 21 days Haematology
14 Whole blood Rituximab 3ml 2 working days Immunology
11 Faecal sample Rotavirus
PCR
pea sized amount 2 days Microbiology
24 Clotted blood samples Rubella IgG and IgM Rubella IgG 170µL, Rubella IgG and IgM 190µL 4 days Virology
24 Serum Salicylate 5 mL 4 hours Clinical Biochemistry
11 Faecal sample Sapovirus
PCR
pea sized amount 2 days Microbiology
24 Serum Selenium 5 mL 7 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 5 Urine - 24 hour Selenium n/a 14 days Clinical Biochemistry
24 Serum Serum Electrophoresis 2 mL 5 working days Immunology
24 Serum SHBG 5 mL 7 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Short Synacthen Test 5 mL 1 day Clinical Biochemistry
35 Urine - Random Sialic acid 5 mL 14 days Clinical Biochemistry
14 Whole Blood Sickle Cell Screen 4 mL 24 hours (confirmatory testing); 1 hour (urgent and request phoned through to lab) Haematology
14 Whole Blood Sirolimus 4 mL 3 days Clinical Biochemistry
24 Serum Skeletal Muscle Antibody 2 mL 21 working days Immunology
24 Serum Skin Antibody (Pemphigus/Pemphigoid) 2 mL 14 working days Immunology
24 Serum Smooth Muscle Antibody 2 mL 4 working days Immunology
35 Urine - Random Sodium 5 mL 1 day Clinical Biochemistry
24 Serum Sodium 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Plasma Somatostatin 5 mL 28 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 5 Urine - 24 hour Steroid Profile (urine) n/a 14 days Clinical Biochemistry
34 Stone Stones - Renal Calculi n/a 14 days Clinical Biochemistry
24 Clotted blood sample Streptococcus serology (antistreptolysin O)
ASO
150µL 6 days Virology
Special Precautions – Please click Test Name for further details 24 Serum Streptomycin <3 days Antimicrobial Reference Laboratory
Special Precautions – Please click Test Name for further details 24 Serum Sulphamethoxazole in Co-trimoxazole <3 days Antimicrobial Reference Laboratory
Special Precautions – Please click Test Name for further details 24 Serum Sulphonylurea 5 mL 28 days Clinical Biochemistry
24 Clotted blood samples Syphilis
RPR
500µL 4 days - Confirmations Virology
24 Clotted blood samples Syphilis confirmation testing - IgG and IgM; Treponemal serology 500µL 4 days - Confirmations Virology
43 Copan swab Syphilis PCR 1 tube 10 days Virology
24 Clotted blood sample Syphilis serology
Total Antibody - Screening
500µL 3 days - Screen Virology
24 Serum Systemic Sclerosis line blot 2ml 2 weeks Immunology
14 Whole Blood T Cell Subsets (see CD4 Counts) 3 mL 1 working day Immunology
Special Precautions – Please click Test Name for further details 14 Whole Blood Tacrolimus 4 mL 3 days Clinical Biochemistry
39 Whole Blood TB (Mycobacterium Blood) 3-5 mL 70 days Microbiology
6 Urine TB (Mycobacterium Urine) 250 mL 70 days Microbiology
34 Sputum/ Pus/ Tissue, NOT Swabs TB (Mycobacterium) samples (other than Blood/ Urine) n/a 70 days Microbiology
Special Precautions – Please click Test Name for further details 24 Serum Teicoplanin <2 days Antimicrobial Reference Laboratory
24 Serum Testis Antibody 2 mL 21 working days Immunology
Special Precautions – Please click Test Name for further details 24 Serum Testosterone 5 mL 1 day Clinical Biochemistry
24 Serum Testosterone confirmation 1 mL 14 days Clinical Biochemistry
24 Serum Tetanus antibodies 2 mL 28 working days Immunology
24 Serum TFT confirmation 1 mL 3 weeks Clinical Biochemistry
24 Serum Theophylline 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Whole Blood Thiamine 4 mL 28 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Whole Blood Thiopurine Metabolites 4 mL 21 days Clinical Biochemistry
14 Whole Blood Thiopurine methyl transferase 4 mL 14 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 13 Whole Blood Thrombophilia Screen 3 full tubes 21 days Haematology
24 Serum Thyroglobulin 5 mL 7 days Clinical Biochemistry
24 Serum Thyroid Function Tests 5 mL 1 day Clinical Biochemistry
24 Serum Thyroid Peroxidase Antibody 2 mL 7 days Clinical Biochemistry
24 Serum Tissue Transglutaminase Antibody 2 mL 7 working days Immunology
Special Precautions – Please click Test Name for further details 24 Serum Tobramycin <1 day Antimicrobial Reference Laboratory
Special Precautions – Please click Test Name for further details 24 Serum Total Bile Acids 5 mL 1 day Clinical Biochemistry
24 Serum Total Protein 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
24 Clotted blood samples Toxoplasma
Total antibody & IgM
500µL 5 days Virology
24 Serum Transferrin Glycoforms 5 mL 14 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 16 Whole Blood Transfusion Reaction 6ml 24 hours Blood Transfusion
1 Aptima Swab Trichomonas vaginalis
NAAT
1 tube 3 days Virology
24 Serum Triglycerides 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Trimethoprim in Co-trimoxazole <3 days Antimicrobial Reference Laboratory
4 Urine - 24 hour Trimethylamine n/a 8 weeks Clinical Biochemistry
24 Serum Troponin I 5 mL 4 hours Clinical Biochemistry
9 Blood spot TSH 2x Spots 7 days Clinical Biochemistry
24 Serum TSH Receptor Antibodies 2ml 8 working days Immunology
24 Serum U/E  (Urea and Electrolytes) 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
24 Serum Urate 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 3 Urine - 24 hour Urate n/a 1 day Clinical Biochemistry
24 Serum Urea 5 mL Hospital patients 4 hours; GP patients 24 hours Clinical Biochemistry
5 Urine Urine Electrolytes n/a 1 day Clinical Biochemistry
35 Urine - Random Urine Electrophoresis 1 mL 5 working days Immunology
28 Urine Urine for MCS 11 mL 3 days Microbiology
Special Precautions – Please click Test Name for further details 5 Urine - 24 hour Urine Free Cortisol n/a 2-3 weeks Clinical Biochemistry
Urine reducing substances
5 Urine Urine Urea n/a 1 day Clinical Biochemistry
5 Urine - 24 hour Urine volume n/a 2 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Valproate 5 mL 7 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 24 Serum Vancomycin 5mL Hospital patients 4 hours Clinical Biochemistry
34 CSF Varicella Zoster
PCR (In house)
200µl 3 days Virology
14 EDTA Blood sample Varicella zoster
PCR (In house)
450µl 3 days Virology
34 Lesion/vesicle fluid Varicella zoster
PCR (In house)
500µl 3 days Virology
43 Vesicle Swab Varicella zoster
PCR (In house)
500µl 3 days Virology
24 Clotted blood samples Varicella zoster IgG 170µL 3 days Virology
24 Serum VEGF 2 mL 21 days Clinical Biochemistry
20 Plasma Very long chain fatty acids 2 mL 21 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Plasma VIP 5 mL 28 days Clinical Biochemistry
Whole Blood Viral Haemorrhagic Fever 7 mL 1 day Virology
0 See link Virology/ Serology (PHE/ REF) n/a 10 days Virology
24 Serum Vitamin A 2 mL 14 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Whole Blood Vitamin B1 4 mL 2 weeks Clinical Biochemistry
24 Serum Vitamin B12 5 mL 3 days Clinical Biochemistry
Special Precautions – Please click Test Name for further details 14 Whole blood Vitamin B6 4 mL 3 weeks Clinical Biochemistry
Special Precautions – Please click Test Name for further details 20 Plasma Vitamin C 2 mL 4 weeks Clinical Biochemistry
24 Serum Vitamin D 5 mL 7 days Clinical Biochemistry
24 Serum Vitamin E 2 mL 14 days Clinical Biochemistry
35 Urine - Random VMA 5 mL 7 days Clinical Biochemistry
13 Whole Blood Von Willebrand's Disease 2.7 mL 3 weeks Haematology
Special Precautions – Please click Test Name for further details Serum Voriconazole < 2 days Antimicrobial Reference Laboratory
Special Precautions – Please click Test Name for further details 13 Plasma Warfarin levels 10 days Haematology
Special Precautions – Please click Test Name for further details 27 Serum and Urine Water Deprivation Test see notes 1 day Clinical Biochemistry
14 Whole Blood White Blood Count 4 mL 24 hours Haematology
Special Precautions – Please click Test Name for further details 14 Whole Blood White Cell Enzymes 5 mL 3-4 weeks Clinical Biochemistry
Special Precautions – Please click Test Name for further details 34 CSF Xanthochromia 1 mL 4 hours Clinical Biochemistry
Special Precautions – Please click Test Name for further details 10 Plasma Zinc 5 mL 7 days Clinical Biochemistry
Zinc Protoporphyrin

Antenatal Booking: Self-refer your pregnancy

Regular Off Off

Please use Badger Notes - Self-refer your pregnancy to BNSSG and complete the form to arrange your first appointment with a midwife at North Bristol NHS Trust.

We recommend you complete the Badger Notes form as soon as you know you are pregnant; it should take approximately 10 minutes to complete.

We will contact you within three working days to offer you an appointment, this will be at the most suitable time to ensure that you are booked for your scan and screening tests within a recommended timeframe.

Appointments are occasionally offered in a neighbouring area to ensure that your appointment is at the optimum time. The first appointment is important and we would appreciate your flexibility to attend the offered appointment.

If you need help completing this form, please contact the booking team, Monday to Friday between 08:00 and 16:00 on 0117 414 6743.

Some pregnant people may require an early appointment:

  • Are you known to be a carrier of sickle cell, abnormal haemoglobin or thalassaemia?
  • Or have you had a pregnancy confirmed to have been affected by Down’s Syndrome, Edward’s syndrome, or Pataus’ syndrome?

If so, in addition to completing the self-referral form, please contact the Screening team for early screening advice on 0117 414 6739

You can find more information about Badger Notes on our dedicated page.

Patient Experience Newsletter

Regular Off Off

Welcome

Hello, I’m Kerry, the new Head of Patient Experience. I will be here whilst Emily is away. It's an honour to join such an amazing team of dedicated people who are committed to putting patients, carers and families at the heart of everything we do. I'm excited to be part of this journey with you and to support you in continuing to achieve great work in all aspects of patient and carer experience - listening to feedback, collaborating and focusing on what really matters to people in our communities.

We have a lot coming up this spring including national Patient Experience Week at the end of April and national Volunteers Week at the start of June. We have our first Carers Awareness Training Session, Gypsy Roma Traveller History Month and more! From April we will be sharing all our Patient Experience social media content under one account. Make sure you are following: NBT Patient Experience Team (@NBTPatient) / X and  North Bristol NHS Trust (@north_bristol_nhs) • Instagram photos and videos

Kerry Than, Head of Patient Experience 

Picture of Kerry Than

 

Volunteer Services

Bwalya Treasure, Volunteer Operational Lead 
Kat Tudor-Thomas, Volunteer Strategic Lead

It’s been an exciting few months, from our wonderful League of Friends funding the purchase of dedicated Carers Chairs, to our volunteers taking part in Learning Disability training. We have also been finalising our Volunteer Services Strategy for the next three years. With a huge amount of input, we will be focusing on ensuring our volunteer offer is welcoming to all. We are excited to launch this. 

League of Friends Team

We are also looking forward to celebrating Volunteers Week at the beginning of June. We are lucky enough to have two UWE photography students doing a volunteer placement with us and taking photos of lots of different volunteers. These photos will form an exhibition in the Brunel building launching during Volunteers Week. This will be a chance to celebrate everything so far, whilst also looking ahead to the next three years!

Volunteer Team

Guest feature 

Ingrid Barker, Joint Chair 

A head and shoulders photo of Ingrid looking at the camera.

It was a pleasure to spend some time with the Patient and Carer Partnership Group recently. We discussed how we can support, amplify and act on the voices of the people we serve as we form our Group with UHBW and begin reshaping some of our clinical services under our Joint Clinical Strategy. 

The group have championed for patients for over 11 years and they help us break down barriers and make improvements. We celebrated all their achievements so far and how we will enhance this going forward. 

It is key, as with everything we do, we ensure we are listening to the people we serve and carers and this group along with our other feedback and outreach, helps to ensure we are moving in the right direction. 

Thank you to all our volunteers, experts by experience and carers who support us in delivering an outstanding experience.

Ingrid Barker and Patient and Carers

Fresh Arts

Art on wards

Donna Baber, Fresh Arts Manager

In summer 2024, Fresh Arts commissioned Jennifer Mills, a visual artist who works with collage and sewing, and Claire Williamson, a creative writer and poet, to collaborate with patients, visitors, and staff on a series of workshops. The aim was to create inspiring and healing artwork for individual bedrooms on ward 26A. 

Themes began to emerge around calming images that can soothe patients; these included a lighthouse, water, beach, and park scenes. Jennifer created four sample images and Claire asked staff to create original words to pair with the images to make each final design unique. In addition to these patient-focused designs, two further artworks were created for the staff rest room which incorporate imagery and text that celebrate the team’s work and culture. 

The artworks were installed in January 2025. Sonia, a patient on the ward, was delighted that the artwork was installed while she was there. She said, “it was an utter joy for me to have the artwork installed in my room. I now have a picture of the beach; the colours of the sea, the sky, the sand are all my favourite colours. I’m using it for meditation and visualisation to help heal and get better. It incorporates everything that is ‘me’ and that would be the place that I would go to; the beach is my happy place. It really is so special to me. It couldn’t have been better timing and it has been a lifeline.”

Photo: First Avenue Photography

Patient with artwork

 

Patient Feedback & Engagement

Hearing all voices

Troy Crompton, Patient Experience Manager

Whilst we have many ways patients can provide feedback such as the Friends and Family Test (FFT), the Patient Advice and Liaison Service (PALS), complaints and other surveys, we also actively engage with patients to ensure we speak to and hear all voices.

A few areas we have been focusing on recently include; 

  • outreach with our Gypsy, Roma, Traveller communities including bringing a patient story video to Trust board of their experiences
  • patient conversations on wards and over the phone, recent focus on speaking to people with a learning disability and/or autism
  • gaining feedback on access from people experiencing homelessness
  • outreach to local visual loss groups with a survey on our work so far
  • understanding the experiences of those who do not speak English

The feedback and insights are shared with the respective areas and steering groups to shape and drive improvements to patient and carer experience.

Carers Event

 

Spiritual, Pastoral and Religious Care (SPaRC) 

Chaplaincy Volunteers Training Course

Mack Kholowa, Team Chaplain

Mack Kholowa, Team Chaplain

One of our aims for 2025 is to be more inclusive and diverse in our volunteer recruitment. Supported by the chaplaincy team, I (Mack Kholowa), ran a 4-week SPaRC training course in January and February. This was attended by nine new volunteers, all from a range of faith, cultural and ethnic backgrounds. 

In March, the volunteers will undertake accompanied ward visits for 3 weeks where they shadow a chaplain and are then observed and supported in their own role. The Volunteers have been allocated to visit Elgar 1, Elgar 2, 25A ,27A, 28B, 6B and Rosa Burden wards. We hope volunteers will start their roles in April 2025. 

The SPaRC Chaplaincy team is hopeful that the new volunteers will support our commitment to providing the best patient experience. By having a wide range of volunteers this will help us support all our patients.

A group of people dancing holding hands during the Volunteer Celebration Event. There are colourful balloons raising up from each of the tables..jpg

Time-to-Transition - Participant Information

Regular Off Off

Would you like to take part in a study about planned caesarean birth?

If you are pregnant with one baby and have chosen to have a caesarean birth at Southmead Maternity Unit, you may be able to take part.

If you would like to request a pdf version of our study information, please email the Study team at: TTT@nbt.nhs.uk

 

Summary of the study

This study is trialling a new method of caesarean birth called “Time-to-Transition". “Time-to-Transition” involves a slower caesarean birth, allowing the baby time to start breathing before it is fully delivered. We propose that this may reduce the chance of babies developing “wet lungs” which can cause breathing difficulty just after birth. We will film the births so we can learn from them. We will collect information about you and your baby, from your medical records.

We will ask you to complete some questionnaires about your birth experience and whether you or your baby have had any extra healthcare in the first month after birth. If you have a birth partner, they will also be invited to complete questionnaires about the birth.

We would like to invite you to take part in the Time-to-Transition Caesarean Birth Study. Please take time to read the information and discuss it with your friends and family. A member of the research team will be happy to answer any questions you may have.

Why is this study being done?

This is a small-scale “feasibility” study, to help us test how the study will run, and to learn if a larger-scale study would be possible.
This study is testing the Time-to-Transition Caesarean Birth method (explained below), which has been developed by Obstetricians and Neonatologists at Southmead Maternity Unit.

Why have I been invited to take part?

We are offering participation in this study to all women who are:

  • having a planned caesarean birth at Southmead Maternity Unit
  • pregnant with one baby
  • and if the baby is in the “head down” position

Why are you testing a Time-to-Transition Caesarean Birth?

Whilst in the womb, a baby’s lungs are filled with fluid, which helps them grow and develop. During labour and birth, most of this fluid goes away, as the baby transitions from life in the womb to breathing air. Some babies might take longer to clear this fluid after they are born, so the lungs can remain “wet” for longer, making it harder to breathe until the fluid clears. When this happens, babies breathe faster and shallower, a condition known as Transient Tachypnea of the Newborn (TTN) and they often need some additional help with breathing, antibiotics to prevent or clear infection, and sometimes a stay in a Neonatal Intensive Care Unit.

TTN is twice as common in babies born by planned caesarean than those born vaginally, as at caesarean births, babies are typically born very quickly and have less time to clear this fluid and transition to breathing air.

In this world-first study, we aim to assess a new way to perform a planned caesarean to increase the time that babies have to transition: a ‘Time-to-Transition Caesarean Birth’.

What is a Time-to-Transition Caesarean Birth?

Rather than being born rapidly after opening the womb, the doctor will deliver the baby’s head and keep the body inside the womb until the baby starts to breathe or to cry, up to a maximum of 2 minutes, before delivering the baby fully. The birth will be filmed using two Hospital cameras. We will ask for your consent to be filmed. If you say no, we can film the birth in such a way that you will not be visible. You can still be involved in this Birth Partner study if you say no to being filmed.

 

 

What does Time-to-Transition mean for me and my baby?

Most of the preparation and aftercare of you and your baby will be the same as in a routine caesarean birth, but there are some important differences.

  1. During the caesarean birth, your doctor will deliver your baby’s head and shoulders as normal. Then, instead of immediately birthing the rest of the baby’s body, the doctor will wait up to two minutes to allow the baby to start breathing or to cry in their own time. The doctor will then deliver the baby’s body and continue care in the normal way. This will make birth of the baby more alike a vaginal birth (where the baby’s head is typically born with one contraction, and then the body is born up to three minutes later with the next contraction).
  2. Your baby’s birth will be filmed using two hospital cameras so we can check the method afterwards
  3. There may be extra Hospital staff at your baby’s birth: a Research Midwife to help with research paperwork and the cameras, and a research Neonatologist to monitor the procedure.

You can still have skin-to-skin and delayed cord clamping if you would like to. As with any caesarean birth, the mother and baby will be closely monitored and if there are any concerns the baby will be immediately delivered. Everything else about the birth and recovery afterwards will remain unchanged.

What are the potential benefits of taking part?

We don’t know if this new method is better than a routine caesarean birth. We hope that the Time-to-Transition birth will reduce the chance your baby will have wet lungs and are less likely to need help breathing, antibiotics, or a stay in NICU. But we can’t be sure. This study will help us find out.
For that reason, we don’t know if there will be any direct benefit to you or your baby, but you may be helping families in the future once the results of this study are known.

Are there any risks?

We don’t expect the Time-to-Transition birth will be riskier to you or your baby. You will both be monitored very carefully during, and after the birth. Your baby will be birthed immediately if there are any concerns about you or your baby.

What will the study involve?

We have designed the study to take as little extra time as possible. If you decide you would like to take part, this is what will happen.

The day you have your baby

  • You will come to Hospital as normal, on the day you are booked to have your baby
  • You will have all the normal checks before you go to Theatre and your care team will prepare you in the normal way
  • You will also be asked to confirm you’re still happy to have the Time-to-Transition caesarean birth
  • We will ask you to complete a "Consent to Filming" form so we can film the birth
  • You (and your birth partner if you have one) will be taken to Theatre where the usual Theatre team will be waiting for you
  • There may also be a Research Midwife and a Neonatologist present.
  • The Doctor will deliver the baby using the Time-to-Transition method. You and your baby will be monitored throughout in the normal way.
  • After the baby is born, you will be cared for in the same way.

The day after your baby is born

  • A Research Midwife will come to see you on the ward before you go home.
  • We will ask you to complete a short questionnaire about your baby’s birth. It takes about 5 minutes to complete.
  • We will collect some information about you and your baby from your Hospital record.

A month after your baby is born

  • We will contact you at home and ask you to complete the questionnaire again.
  • We will also ask you some questions about whether you or your baby have had any extra care such as GP appointments, or Hospital appointments.

 

 

Can my birth partner be involved?

If you have a birth partner, they can be present at your baby’s birth, just as they would if you weren’t part of the study. We will ask them for their consent to being filmed during the birth. If they say no, we will film the birth in such a way that they are not visible.

We would also like to invite them to be a part of the Birth Partner study which involves them completing the questionnaire about birth experiences after your baby is born. If they say no, you can still be involved in this study.

Can I have a copy of the video?

Yes, if you would like it, you can request a copy. You can still bring your own camera to take your own pictures on the day.

What is the recovery time?

We don’t think your recovery time would be any different to if you were having a routine caesarean birth.
You will be cared for in the same way after the birth. More information about Caesarean birth and recovery can be found at

Caesarean Birth | North Bristol NHS Trust
(nbt.nhs.uk) or by watching this video
https://youtu.be/WEwH5WwMjoE

Who is doing the study?

This study is being carried out by staff at North Bristol NHS Trust and the University of the West of England.

 

How is this study funded?

This study is funded by donations made to the Southmead Hospital Charity.

Who has reviewed this study?

The Health Research Authority and South Central Berkshire Research Ethics Committee (B) REC: 23/SC/0228 IRAS project ID: 325202 have reviewed and agreed to this study.

What happens next?

If you are eligible and interested in learning more, a Research Midwife will talk to you and help you decide if you'd like to take part in this study. If you would still like to take part, they will ask you to complete a consent form.

What if I change my mind?

You can change your mind and withdraw from this study at any time and without giving a reason, but we will keep information about you that we already have. If you do not want this to happen, tell us and we will stop. It will not affect the care that you receive, nor that of the person you are birth partner for.

We will ask you to let us know your preference by completing a study withdrawal form.

We need to manage your records in specific ways for the research to be reliable. This means that we won’t be able to let you see or change the research data we hold about you. If you agree to take part in this study, you will have the option to take part in future research using your data saved from this study.

 

 

 

 

How will my information be used?

All research in the UK, which uses patient information must follow UK law (the Data Protection Act) and GDPR* rules.

North Bristol NHS Trust (UK) is the Sponsor for this study. This means we are responsible for looking after your information and using it properly, according to the rules and law.

In this questionnaire study we will need to use some information about you. This information will include your name, contact details and some basic information such as your age and ethnicity. We will use your contact details to get in touch with you by phone, email, or text.

We will keep all information about you safe and secure. People who do not need to know who you are will not need to see your name or contact details. Your data will be given a code number instead. We will write our reports in such a way that no one can work out who took part in the study.

Once we have finished the research study, we will keep some of the data so that we can check the results. We will store study data for up to 5 years after the end of the project, as per standard protocol at North Bristol NHS Trust. We will write our reports in such a way that no one can work out who took part in the study.

(*GDPR stands for General Data Protection Regulation)

Where can I find more about how my information will be used?

North Bristol NHS Trust is the sponsor for this study. You can find out more about how we use your information at:

Patient Data & Research Privacy Policy | North Bristol NHS Trust (nbt.nhs.uk)

www.hra.nhs.uk/information-about-patients.

You can also:

  • Ask one of the research team
  • Contact Helen Williamson (Head of Information Governance) at helen.e.williamson@nbt.nhs.uk or by calling 0117 4144767

What if there are any problems?

NHS-sponsored research such as this study is covered by NHS indemnity (the same indemnity that applies to any patient in the NHS). In the unlikely event that you feel you have been adversely affected by taking part in this study, you should contact the research team as soon as possible. 

Should you wish to complain about any aspect of the way you have been approached or treated during the study, the normal NHS complaints mechanisms are available to you.

Please visit www.nbt.nhs.uk/patients-carers/feedback for further information about how to make a complaint or contact the North Bristol NHS Trust Hospital Patient Advice and Liaison Service (PALS): Telephone 0117 414 4569. PALS can also provide confidential advice and support to patients, families, and their carers.

Who should I contact if I have any questions?

The study is being led by Dr Joanna Crofts at Southmead Hospital (North Bristol NHS Trust). If you have any questions about the study please contact Dr Joanna Crofts, Consultant Obstetrician, Southmead Hospital either by:

The Study Email address: TTT@nbt.nhs.uk

Telephone: 01174146764

 

 

R&I W&C Banner.png

Time-to-Transition - Birth Partner Information

Regular Off Off

If you are birth partner to someone who has chosen to take part in the Time-to-Transition Caesarean Birth Study, you may be able to take part in this questionnaire study.

If you would like to request a pdf version of our study information, please email the Study team at: TTT@nbt.nhs.uk

What is a Time-to-Transition Caesarean Birth?

The main study is testing the Time-to-Transition Caesarean Birth method, which has been developed by Obstetricians and Neonatologists at Southmead Maternity Unit.

Rather than being born rapidly after opening the womb, the doctor will deliver the baby’s head and keep the body inside the womb until the baby starts to breathe or to cry, up to a maximum of 2 minutes, before delivering the baby fully. The birth will be filmed using two Hospital cameras. We will ask for your consent to be filmed. If you say no, we can film the birth in such a way that you will not be visible. You can still be involved in this Birth Partner study if you say no to being filmed.

 

 

Why have I been invited to take part?

As you are the birth partner of someone who has agreed to take part in the Time-to-Transition Caesarean Birth study, we would like to invite you to take part too, by sharing your thoughts about your experiences of the birth. If you decide not to take part, the person who you are birth partner to can still be involved in the study.

Are there any benefits to taking part?

There will not be any direct benefit to you in taking part, but you may be helping families in the future once the results of this study are known.

Are there any risks?

This is a questionnaire study and there will be no risk to you.

To find out more about the possible benefits or risks to the caesarean birth itself, please refer to the “Time-to-Transition Caesarean Birth Study” information leaflet. (where can this be found)??

How much time will it take?

If you agree to take part, we will ask you some questions about yourself (such as age and ethnicity).

We will also ask you to complete a short questionnaire about your experience as a birth partner to a participant of the main study

  • once just after the baby’s birth and
  • once when the baby is about a month old.

Each questionnaire will take about 5-10 minutes to complete, and can be done over the phone, or on a smartphone or computer if you have one.

Who is doing the study?

This study is being carried out by staff at North Bristol NHS Trust and the University of the West of England.

 

How is this study funded?

This study is funded by donations made to the Southmead Hospital Charity.

Who has reviewed this study?

The Health Research Authority and South Central Berkshire Research Ethics Committee (B) REC: 23/SC/0228 IRAS project ID: 325202 have reviewed and agreed to this study.

What happens next?

If you are eligible and interested in learning more, a Research Midwife will talk to you and help you decide if you'd like to take part in this study. If you would still like to take part, they will ask you to complete a consent form.

What if I change my mind?

You can change your mind and withdraw from this study at any time and without giving a reason, but we will keep information about you that we already have. If you do not want this to happen, tell us and we will stop. It will not affect the care that you receive, nor that of the person you are birth partner for.

We will ask you to let us know your preference by completing a study withdrawal form.

We need to manage your records in specific ways for the research to be reliable. This means that we won’t be able to let you see or change the research data we hold about you. If you agree to take part in this study, you will have the option to take part in future research using your data saved from this study.

 

 

 

 

How will my information be used?

All research in the UK, which uses patient information must follow UK law (the Data Protection Act) and GDPR* rules.

North Bristol NHS Trust (UK) is the Sponsor for this study. This means we are responsible for looking after your information and using it properly, according to the rules and law.

In this questionnaire study we will need to use some information about you. This information will include your name, contact details and some basic information such as your age and ethnicity. We will use your contact details to get in touch with you by phone, email, or text.

We will keep all information about you safe and secure. People who do not need to know who you are will not need to see your name or contact details. Your data will be given a code number instead. We will write our reports in such a way that no one can work out who took part in the study.

Once we have finished the research study, we will keep some of the data so that we can check the results. We will store study data for up to 5 years after the end of the project, as per standard protocol at North Bristol NHS Trust. We will write our reports in such a way that no one can work out who took part in the study.

(*GDPR stands for General Data Protection Regulation)

Where can I find more about how my information will be used?

North Bristol NHS Trust is the sponsor for this study. You can find out more about how we use your information at:

Patient Data & Research Privacy Policy | North Bristol NHS Trust (nbt.nhs.uk)

www.hra.nhs.uk/information-about-patients.

You can also:

  • Ask one of the research team
  • Contact Helen Williamson (Head of Information Governance) at helen.e.williamson@nbt.nhs.uk or by calling 0117 4144767

What if there are any problems?

NHS-sponsored research such as this study is covered by NHS indemnity (the same indemnity that applies to any patient in the NHS). In the unlikely event that you feel you have been adversely affected by taking part in this study, you should contact the research team as soon as possible. 

Should you wish to complain about any aspect of the way you have been approached or treated during the study, the normal NHS complaints mechanisms are available to you.

Please visit www.nbt.nhs.uk/patients-carers/feedback for further information about how to make a complaint or contact the North Bristol NHS Trust Hospital Patient Advice and Liaison Service (PALS): Telephone 0117 414 4569. PALS can also provide confidential advice and support to patients, families, and their carers.

Who should I contact if I have any questions?

The study is being led by Dr Joanna Crofts at Southmead Hospital (North Bristol NHS Trust). If you have any questions about the study please contact Dr Joanna Crofts, Consultant Obstetrician, Southmead Hospital either by:

The Study Email address: TTT@nbt.nhs.uk

Telephone: 01174146764  - between 9 am to 4pm.

 

 

R&I W&C Banner.png

About the Time-to-Transition Study

Regular Off Off

Time to Transition Caesarean Birth: A new study is taking place to determine if a Time-to-Transition caesarean birth improves the health of new born babies.

What is this feasibility study about? And why are we doing it?

Background: 

In the womb, a baby’s lungs are filled with fluid, which helps them develop. During labour and birth, most of this fluid goes away, and the baby adapts to breathing air.

When babies are born quickly by caesarean, they may not have enough time to clear the fluid, so the lungs remain “wet”, making it harder to breathe. They breathe faster and shallower, a condition called Transient Tachypnea of the Newborn (TTN), and often need antibiotics, breathing support, and a stay in a Neonatal Intensive Care Unit.

Reducing TTN could reduce the need for this extra care.

This study will assess a new ‘Time-to-Transition Caesarean Birth’. 

Rather than being born rapidly after opening the womb, the doctor will deliver the baby’s head, keeping the body inside the womb until the baby starts to cry (for a maximum of 2 minutes). This extra time may help the baby transition to breathing air and reduce the risk of TTN.

As with any caesarean, the mother and baby will be closely monitored. If there are any concerns the baby will be immediately delivered. Everything else about the birth and recovery remain unchanged.

How will the research be carried out?

Methods: 

We will recruit 34 women to have a “Time-to-Transition Caesarean Birth”.

Women can take part if they are:

  • pregnant with one baby
  • planning a Caesarean birth
  • and if baby’s position is “head-down”

We will:

  • video the births, to learn from them.
  • collect information about mother and baby from their medical records
  • ask the views of mothers, birth partners, and clinicians

Future Direction

If this study demonstrates that it’s feasible and is acceptable, we will undertake a large-scale study comparing newborn outcomes after Time-to-Transition” and standardcaesarean births.

Project Details:

Chief Investigator: Dr Joanna Crofts, Consultant Obstetrician

Planned End Date: July 2024

Local Ref: 5238 

R&I W&C Banner.png

Dementia Research Case study

Regular Off Off

More than 55 million people have dementia worldwide with nearly 10 million new cases every year.

Researchers have learned that changes in the brains of people with Alzheimer’s disease start as many as 20 years before they notice symptoms like memory problems.

Amyloid is a protein that builds up in the brains of people who have AD. This build-up of amyloid protein in the brain is called “amyloid plaque” and may lead to impairment in memory and thinking. Research studies suggest that people with normal memory performance who have elevated levels of brain amyloid are at increased risk for memory problems, but not every person with amyloid build up will develop memory problems or AD dementia.

At NBT we are one of 100 sites world-wide who are asking volunteers between the age of 55 to 80 years of age to take part in the AHEAD A-45 study, to see if a study treatment with BAN2401 (also known as lecanemab)  can help reduce the risk of developing Alzheimer’s disease.

The Bristol Brain Centre is one of the only brain health clinical services in the country. It has a strong research ethic offering research opportunities to people with and without dementia.

The research focuses on early diagnosis of dementia, understanding how memory is stored in the brain and how this can be enhanced through clinical trials.

We were privileged to interview Rob, who is taking part in the study and shares with us his experiences and hopes for the future.

 

Video Script

I'm Rob and I'm a retired enjoying my time in retirement so it's given me the chance to do all sorts of new things and get involved in activities I love walking I celebrated my retirement by walking a thousand miles around the coast of Wales with a tent on my back and just to prove that I was fit and I have done various long distance paths in the in the country.

So to take part in the study you you've got to have a degree of Alzheimer's dementia and which indeed they found,  and to take part you've got to be prepared for that discovery to be made and take it from there I believe,  that I ought to be doing everything  I can to help any research into dementia as something that's important to me.

The actual assessment process encompasses various tests and things, that obviously  makes you cause you to wonder what they're going to discover about you.  But, in fact I wasn't  too worried about that or concerned. Everybody was extremely caring and at every stage everything that they were doing was explained clearly and the reassurance at every level was good.  As I have said before at any stage I  was encouraged to withdraw if I had the slightest concern about doing something I wasn't comfortable doing.

Having been accepted onto the trial it was a moment of excitement for me. I was very pleased to do it and pleased that I've been accepted.

I think the major thing about once you are accepted and being able to be accepted is that you've got to be prepared to commit time. It's a four-year study and you are required to go to the brain Centre in Southmead for once a month for several hours and that for me was my major consideration rather than any consideration about my own health.

I attend the Bristol Brain Centre every month for a few hours and I receive an infusion of the drug or a placebo I don't know which. I also have regular cognitive tests health checks and a MRI brain scan every three months.

To not know whether you're having the actual drug or the placebo is rather strange to begin with but you get you get used to the Cloak and Dagger bits of the actual liquid being covered in a black bag so that nobody knows what's happening it's all quite exciting really.

It's made clear at the beginning of the trial that you will never know and you have to accept that as part of the condition of taking part. To anyone thinking of taking part in this study and not necessarily this one, just be open about it I think I'd recommend anybody to put themselves forward for assessment.

You lose nothing by being assessed you perhaps gain something by finding something out about yourself as long as you're prepared for that to happen.

The big decision about whether to take part in the trial comes after the assessment, so, yes you could consider it. I would encourage you to do so.

I hope my participation and those of the other people taking part in the trial across the world that at least the quality of life for people who suffer in dementia can be improved. Ends

Take Part in Research

Patient & Doctor viewing an x-ray

Become one of the thousands of people taking part in research every day within the NHS.

About Research & Development

NBT Researcher

Find out more about our research and how we're working to improve patient care.

Contact Research

Research & Development
North Bristol NHS Trust
Level 3, Learning & Research building
Southmead Hospital
Westbury-on-Trym
Bristol, BS10 5NB

Telephone: 0117 4149330
Email: research@nbt.nhs.uk

Dementia
R&I Dementia.jpg

AAC Assessment (Training for Local Paediatric and Local Adult Learning Disability Teams)

Regular Off Off

AAC Assessment (Training for Local Paediatric and Local Adult Learning Disability Teams)

We are pleased to be able to offer this free online training course via Microsoft Teams.  

The course is a full day and consists of both theory and practical exercises outlining models, tools and access considerations for assessing children and adults with learning difficulties. 

We will ask those attending to bring a case study with them to share and relate their learning to. A template for case studies will be sent out to attendees a week before the course date. There will be opportunities to ask any specific questions you have and learn more about the service AAC WEST offers.

Available dates:

Tuesday 15th October 2024 - Book here with Eventbrite